首页> 外国专利> New synergistic combination of an anticoagulant and unicellular parasite sporocysts, e.g., warfarin and Sarcocystis singaporensis sporocysts, is useful in killing rodents

New synergistic combination of an anticoagulant and unicellular parasite sporocysts, e.g., warfarin and Sarcocystis singaporensis sporocysts, is useful in killing rodents

机译:抗凝剂和单细胞寄生虫孢子囊的新的协同组合,例如华法林和新加坡Sarcocystis孢子囊,可用于杀死啮齿动物

摘要

Novel agent comprises sporocysts of at least one type of unicellular parasite and at least one anticoagulant active agent. - ACTIVITY : Rodenticidal; anticoagulant. In tests, brown rats ( Rattus norvegicus) were treated with Sarcocystis singaporensis sporocysts, coumatetralyl or a combination of these two components. A first group of rats was treated with a suspension of 10,000 sporocysts in 0.5 ml of polyethylene glycol 300, and all rats survived. A second group was treated with coumatetralyl (6 mg/kg) using 0.06 ml of a 1% solution of the active agent in polyethylene glycol 300, and 5 out of 6 rats survived. A third group of rats was treated with 10,000 sporocysts and 6 mg/kg coumatetralyl, and all rats died. - MECHANISM OF ACTION : None given.
机译:新药包括至少一种单细胞寄生虫的孢子囊和至少一种抗凝血活性剂。 -活动:杀鼠;抗凝物。在测试中,用Sarcocystis singaporensis孢子囊,coumatetralyl或这两种成分的组合治疗了棕色大鼠(Rattus norvegicus)。第一组大鼠用10,000个孢子囊在0.5 ml聚乙二醇300中的悬浮液处理,所有大鼠存活。第二组使用0.06 ml的1%活性剂在聚乙二醇300中的溶液用香豆基酯(6 mg / kg)治疗,每6只大鼠中有5只存活。第三组大鼠接受10,000个孢子囊和6 mg / kg coumatetralyl治疗,所有大鼠死亡。 -作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号